Earnings Call · Q3 FY2024·2024-11-04

Q3 24EPS +1.11%·Rev n/aQ2 24EPS -6.06%·Rev n/aQ1 24EPS -80.00%·Rev n/aQ4 23EPS +100.00%*·Rev n/a⚠ consensus missing

Krystal Biotech, Inc. KRYS

Stéphane Paquette — Vice President of Corporate Development

Krish Krishnan — Chief Executive Officer

Jennifer McDonough — Head of Patient Access or Patient Access Leader

Christine Wilson — Head of Commercial or Commercial Leader

Suma Krishnan — Head of Development or Development Leader

Kate Romano — Chief Financial Officer

−3.1%1d on move date−2.9% vs SPY3d+3.8%5d+13.2%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more KRYS calls or request research access.

More KRYS calls Browse calls Request research access